[go: up one dir, main page]

BR0314716A - Anticorpos de subunidade alfa de lfa-1 e métodos de uso - Google Patents

Anticorpos de subunidade alfa de lfa-1 e métodos de uso

Info

Publication number
BR0314716A
BR0314716A BR0314716-9A BR0314716A BR0314716A BR 0314716 A BR0314716 A BR 0314716A BR 0314716 A BR0314716 A BR 0314716A BR 0314716 A BR0314716 A BR 0314716A
Authority
BR
Brazil
Prior art keywords
lfa
alpha subunit
methods
subunit antibodies
antibodies
Prior art date
Application number
BR0314716-9A
Other languages
English (en)
Inventor
Pamela M Kapustay
Rex H Lewis
Original Assignee
Aids Res Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32029897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0314716(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aids Res Llc filed Critical Aids Res Llc
Publication of BR0314716A publication Critical patent/BR0314716A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"ANTICORPOS DE SUBUNIDADE ALFA de LFA-1 E MéTODOS DE USO". São fornecidos anticorpos úteis para tratar condições fisiológicas e doenças associadas com a subunidade alfa de LFA-1, doenças essas tratáveis com um anticorpo que se liga à subunidade alfa de LFA-1, tal como HIV, e métodos para tratar essas doenças.
BR0314716-9A 2002-09-27 2003-09-25 Anticorpos de subunidade alfa de lfa-1 e métodos de uso BR0314716A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/261,164 US6919077B2 (en) 2002-09-27 2002-09-27 LFA-1 alpha subunit antibodies and methods of use
PCT/US2003/030529 WO2004029214A2 (en) 2002-09-27 2003-09-25 Lfa-1 alpha subunit antibodies and methods of use

Publications (1)

Publication Number Publication Date
BR0314716A true BR0314716A (pt) 2005-07-26

Family

ID=32029897

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314716-9A BR0314716A (pt) 2002-09-27 2003-09-25 Anticorpos de subunidade alfa de lfa-1 e métodos de uso

Country Status (9)

Country Link
US (3) US6919077B2 (pt)
EP (1) EP1545601A4 (pt)
JP (1) JP2006501283A (pt)
CN (1) CN1703240A (pt)
AU (1) AU2003277003A1 (pt)
BR (1) BR0314716A (pt)
CA (1) CA2499924A1 (pt)
WO (1) WO2004029214A2 (pt)
ZA (1) ZA200503173B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951306A4 (en) * 2005-10-14 2010-08-11 Hopkins J School Of Medicine REDUCTION AND PREVENTION OF CELL ASSOCIATED HIV TRANSEPITHEL MIGRATION, MICROBICIDES AND OTHER FORMULATIONS AND METHODS
WO2007070488A2 (en) * 2005-12-12 2007-06-21 The Cbr Institute For Biomedical Research, Inc. Integrin alpha l i domain mutants with increased binding affinity
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
EP2721147B1 (en) * 2011-06-17 2018-04-25 CytoDyn, Inc. Methods of treating retroviral infections in felines
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
WO2013040188A1 (en) * 2011-09-15 2013-03-21 Cytodyn, Inc. Anti-cd11a antibodies and uses thereof
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2983711A4 (en) * 2013-04-08 2016-11-23 Cytodyn Inc FELLINED ANTIBODIES AND METHODS OF TREATING RETROVIRAL INFECTIONS IN FELINES
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002869A (en) 1987-11-02 1991-03-26 Dana-Farber Cancer Institute Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes
JP3976333B2 (ja) * 1992-09-16 2007-09-19 ザ スクリップス リサーチ インスティチュート 呼吸合胞体ウイルスに対するヒト中和性モノクローナル抗体
US5651970A (en) 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
ATE267019T1 (de) * 1993-03-19 2004-06-15 D Allen Allen Methoden zur inhibition von hiv-assotiierte krankheit mittels monoklonaler antikörper gegen sich selbstgerichtete zytotoxische t-zellen
US6534057B2 (en) * 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies

Also Published As

Publication number Publication date
CA2499924A1 (en) 2004-04-08
AU2003277003A1 (en) 2004-04-19
JP2006501283A (ja) 2006-01-12
EP1545601A4 (en) 2006-07-05
US6919077B2 (en) 2005-07-19
US20080038259A1 (en) 2008-02-14
CN1703240A (zh) 2005-11-30
WO2004029214A3 (en) 2005-02-03
US20050142134A1 (en) 2005-06-30
WO2004029214A8 (en) 2004-07-22
ZA200503173B (en) 2006-10-25
US20040062765A1 (en) 2004-04-01
EP1545601A2 (en) 2005-06-29
WO2004029214A2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
BR0314716A (pt) Anticorpos de subunidade alfa de lfa-1 e métodos de uso
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
CR7786A (es) Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BR0308211A (pt) Cumarinas úteis como biomarcadores
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
HN2006019066A (es) "(s)-n-metilnaltrexona"
BR0114628A (pt) Membro de retenção em microprojeção para aplicador de impacto
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
BRPI0411900A (pt) compostos antivirais e métodos
BR0013825A (pt) Formas de apresentação de tramadol
BR0307702A (pt) Formulações de solução contendo anticorpo
UY29700A1 (es) "8-(3-amino-piperidin-1-il)-xantinas, su preparación y su uso como medicamentos
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
BRPI0501450A (pt) Composição funcional, e, artigo
ECSP066559A (pt)
BR9811948A (pt) Secretores de hormÈnio do crescimento
AR043783A1 (es) Difenilazetidinona con propiedades fisiologicas, medicamentos que comprenden este compuesto y su uso
BR112021021645A2 (pt) Anticorpos anti-hvem e uso dos mesmos.
BR0116686A (pt) Anticorpos anti-cd28 silenciados e uso dos mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.